Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

AGA might indicate higher risk for severe COVID-19.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Upadacitinib may effectively treat resistant lichen planopilaris.

Adiantum capillus extract reduces pain and swelling in animals.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

5-ARI therapy may help prevent prostate cancer progression.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.